BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Postoperative Nausea and Vomiting readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Postoperative Nausea 
 and Vomiting\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07709897-11094@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS5580: Phase 2 readout est. (NCT07709897)
DESCRIPTION:HRS5580\, phase 2\, Postoperative Nausea and Vomiting.\nStudy: 
 A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydro
 chloride for the Prevention of Postoperative Nausea and Vomiting\nEstimate
 d primary completion: December 2026. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/hrs5580#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07709897
URL:https://assetmemo.bio/drug/hrs5580#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
